|本期目录/Table of Contents|

[1]李慧慧,毛富强,韩邵明,等.内观认知疗法对精神分裂症患者服药依从性的影响[J].天津医科大学学报,2017,23(06):548-551.
 LI Hui-hui,MAO Fu-qiang,HAN Shao-ming,et al.Effect of Naikan CognitiveTherapy on medication adherence in schizophrenic patients[J].Journal of Tianjin Medical University,2017,23(06):548-551.
点击复制

内观认知疗法对精神分裂症患者服药依从性的影响(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23
期数:
2017年06期
页码:
548-551
栏目:
精神医学
出版日期:
2017-11-20

文章信息/Info

Title:
Effect of Naikan CognitiveTherapy on medication adherence in schizophrenic patients
文章编号:
1006-8147(2017)06-0548-04
作者:
李慧慧12毛富强1韩邵明12常 琦12程 娟1
(1.天津医科大学精神医学教研室,天津300070;2.天津市公安局安康医院第四治疗所,天津 300240)
Author(s):
LI Hui-hui12 MAO Fu-qiang1 HAN Shao-ming12 CHANG Qi12 CHENG Juan1
(Department of Psychiatry, Tianjin Medical University, Tianjin 300070,China; 2.The Fourth Clinic,The Ankang Hospital of Tianjin Public Security Bureau, Tianjin 300240,China)
关键词:
精神分裂症服药依从性内观认知疗法
Keywords:
schizophrenia medication adherence Naikan Cognitive Therapy
分类号:
R749.3
DOI:
-
文献标志码:
A
摘要:
目的 评价内观认知疗法对精神分裂症患者服药依从性的影响。方法:将稳定期患者随机分成研究组和对照组,研究组在药物治疗同时予以8周内观认知治疗,对照组在药物治疗同时予以8周工娱治疗。两组患者分别在治疗前及治疗后8周、半年时进行PANSS、ITAQ及MARS测试。结果治疗前研究组与对照组在一般资料、PANSS、ITAQ和MARS评分均无显著性差异(P>0.05);在治疗8周后及6个月随访时,研究组PANSS、ITAQ和MARS评分改善较对照组差异有统计学意义(P<0.05)。结论:内观认知疗法可以显著提高精神分裂症患者服药依从性。
Abstract:
Objective:To investigate the effect of NaikanCognitive therapy onmedication adherence in schizophrenic patients.Methods:Schizophrenic patients were divided into research group and control group randomly. Drug treatment and Naikan Cognitive Therapy were given to the research group for 8 weeks. At the same time, the control group was treated with drug and work entertainment for 8 weeks. Two groups of patients were tested PANSS,ITAQ,MARSscores before and after treatment, respectively.Results: There was no significant difference between the two groups in terms of general information (P>0.05); There was no significant difference between the two groups in PANSS,ITAQ,MARS before treatment either(P>0.05); During the treatment for 8 weeks tohalf a year, PANSS,ITAQ, MARS scores of the research group improved significantly compared with the control group(P<0.05).Conclusion: Naikan Cognitive Therapy can significantly improve the medication adherence of schizophrenic patients.

参考文献/References:

[1]Muller R.Managed care considerations.Optimal pharmacotherapyof schizophrenia[J].Managed Care,2014,23(4Suppl 1):4

[2]Chan KW,Hui LM,Wong HY,et al. Medication adherence,knowledgeabout psychosis, and insight among patients with a schizophreniaspectrum disorder[J].J Nervous Mental Dis,2014,202(1):25

[3]Sariah AE,Outwater AH,Malima KI. Risk and protective factorsfor relapse among individuals with schizophrenia: a qualitativestudy in Dares Salaam,Tanzania[J].BMC Psychiatry,2014,14(1):1

[4]毛富强.内观认知疗法理论与操作[J].中华行为医学与脑科学杂志,2016,25(7): 650

[5]王勋,马宁,张五芳,等.精神分裂症患者服药依从性的评价方法[J].中国心理卫生杂志,2014,28(1):45

[6]Fialko L, Garety PA, KuipersE,etal. A large-scale validationstudy of the Medication Adherence Rating Scale (MARS)[J].Schizophr Res,2008,100(1/3):53

[7]江开达, 李淑春, 罗星光,等.精神分裂症病人维持治疗中的依从性研究[J].中华精神科杂志, 1997,30(2):167

[8]李冬梅.精神障碍患者服药不依从行为相关因素分析及护理干预[J].中国当代医药,2013,20(25):180

[9]屈金莲,张涛,宋杰,等.出院后精神分裂症患者服药依从性电话和短信干预的1 年随访[J].中国心理卫生杂志,2015,29(9):656

[10]王飞,胡群英,李宁.内观疗法对首发精神分裂症服药依从性及复发影响探究[J].亚太传统医药,2013,9(2):102

[11]茅荣杰,朱光,罗碧明,等.内观疗法与行为疗法对精神分裂症患者近期服药依从性的影响[J].临床精神医学杂志,2014,24(4):217

[12] 毛富强.内观认知疗法[J].中华医学信息导报,2011,26(2):20

[13]Buckley A F,Wirshing DA,Bhushan P,etal. Lack of insight inschizophrenia: impact on treatment adherence[J].CNS Drugs,2007,21(2):129

[14]Rusch N,Todd AR,Bodenhausen GV,etal.Implicate versus explicitattitudes toward psychiatric medication: Implications for insight andtreatment adherence[J].Schizophr Res,2009,112(1/3):119

[15]毛富强.内観療法治療効果と心理機制の体験[J].日本内観研究,2009,15(1):67

[16] 程娟,徐小童,毛富强,等.内观认知疗法改善偏执型精神分裂症康复期社会功能的研究[J].天津医科大学学报.2014,20(4):313

[17]黄美莲,钟丽红,钟飞英.电话随访对粤北地区100例精神分裂症患者出院后的影响研究[J].中国民康医学,2011,23(23):2975

[18]施永斌,何琼娜,褚庆文,等.药物自我处置技能训练对分裂症患者服药依从性的影响[J].中国健康心理学杂志,2012,20(10):1477

相似文献/References:

[1]陈清刚,钱 明,王 毅,等.首发精神分裂症患者与超高危人群认知功能的对照研究[J].天津医科大学学报,2014,20(03):216.
 CHEN Qing gang,QIAN Ming,WANG Yi,et al.Control study of cognitive function in ultra-high risk population of schizophrenia and first-episode schizophrenia patients[J].Journal of Tianjin Medical University,2014,20(06):216.
[2]程 娟,徐小童,毛富强,等.内观认知疗法改善偏执型精神分裂症康复期社会功能的研究[J].天津医科大学学报,2014,20(04):313.
[3]田 丽,杨 媛,胡永梅.首诊精神分裂症患者的病耻感与社会功能的关系研究[J].天津医科大学学报,2014,20(06):480.
[4]张 静,赵永萍,贾 琼,等.黄连素对利培酮治疗精神分裂症患者症状及糖脂代谢的影响[J].天津医科大学学报,2016,22(04):338.
[5]马彦彦,李美娟,仇玉莹,等.盐酸小檗碱对精神分裂症患者脂代谢及C反应蛋白的影响[J].天津医科大学学报,2018,24(02):159.
[6]杜 彬,杨建立.氟西汀辅助治疗前后精神分裂症患者外周血miR-181b 表达差异研究[J].天津医科大学学报,2019,25(01):63.
 DU Bin,YANG Jian-Li.Study on the difference of miR-181b expression in patients with schizophrenia before and after fluoxetine treatment[J].Journal of Tianjin Medical University,2019,25(06):63.
[7]崔 鹏,杨建立.奥卡西平治疗的精神分裂症兴奋激越患者的效果及对血清Hcy的影响[J].天津医科大学学报,2019,25(01):66.
 CUI Peng,YANG Jian-Li.Effect of oxcarbazepine on patients with schizophrenia and excitement and its effect on serum Hcy[J].Journal of Tianjin Medical University,2019,25(06):66.
[8]马晓雷,孙焕君,和西波,等.中国精神分裂症患者认知能损害性别差异的P300证据[J].天津医科大学学报,2019,25(02):167.
 MA Xiao-lei,SUN Huan-jun,HE Xi-bo,et al.P300 evidence for the gender difference in cognitive impairment in Chinese patients with schizophrenia[J].Journal of Tianjin Medical University,2019,25(06):167.

备注/Memo

备注/Memo:
作者简介 李慧慧(1985-),女,主治医师,硕士在读,研究方向:临床精神病学;

通信作者:毛富强,E-mail:maofq@tmu.edu.cn。

更新日期/Last Update: 2017-11-14